Jianglin Zheng
Papers
1
Total Citations
2
H-Index
1
About
Dr. Jianglin Zheng is a leading surgical oncologist whose research focuses on optimizing surgical approaches for hepatocellular carcinoma (HCC), particularly through comparative effectiveness studies. His most influential work examines the clinical and economic outcomes of robotic-assisted, laparoscopic, and open liver resection for BCLC stage 0/A HCC. In his landmark 2025 nationwide cohort study, Dr. Zheng systematically compared these three surgical modalities, providing critical evidence on their relative benefits in terms of perioperative outcomes, oncologic efficacy, and healthcare costs. This research has already garnered significant attention, accumulating 2 citations shortly after publication, and is shaping clinical decision-making for early-stage HCC patients. Dr. Zheng’s contributions are particularly notable for their real-world, population-level analysis, offering surgeons and policymakers actionable data on the trade-offs between minimally invasive techniques and traditional open surgery. His work addresses a longstanding debate in hepatobiliary surgery, helping to clarify which patients benefit most from robotic or laparoscopic approaches versus conventional hepatectomy. By integrating clinical outcomes with economic analysis, Dr. Zheng’s research supports value-based care in surgical oncology, making him a key voice in the evolution of liver cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1